Previous studies have demonstrated that mindfulness-enhanced exercise training (MEET) exerts positive effects on mental health of college students. This research aims to compare the similarities and differences in efficacy, trajectories of effects, and the underly mechanism between two distinct types of MEET, which integrates mindfulness practices with tai chi (MTC) or resistance training (MR)....
Interest and use of psychedelic substances is on the rise in the general population. Research has mainly focused on therapeutic applications in formal treatment settings, and little is known about persistent negative effects in naturalistic use. The aim of this paper is to present a clinically relevant overview of the phenomenology and symptoms of enduring mental health problems after...
This study investigated the efficacy of an integrated psycho-yogic training program on psychological well-being in underperforming female athletes, addressing the gap in traditional sports training that often neglects psychological readiness. The research involved 56 female athletes aged 20-25 years, randomly divided into experimental and control groups of 28 participants each. The experimental...
Abstract Early maladaptive schemas (EMS) are highly prevalent in patients seeking psychedelic-assisted psychotherapy and correlate strongly with baseline depression and anxiety. This study characterized EMS in 192 adults and longitudinally followed 74 patients receiving psilocybin- or LSD-assisted therapy. We found that baseline schema burden, particularly related to failure and defectiveness,...
Eating disorders (EDs) are complex psychiatric conditions characterized by disruptions in eating behaviors, body image concerns, and profound medical and psychosocial consequences. Despite their significant global prevalence, coupled with high morbidity and mortality rates, pharmacological treatment options remain limited. This review synthesizes evidence from clinical drug trials conducted...
Abstract First-hand experience with psychedelics may help clinicians develop skills and knowledge needed to work with the profound changes to conscious awareness occasioned by psychedelics. However, the topic remains contentious and underexplored. In this world-first study, we investigated the utility of psilocybin experiential therapist training in a sample of 14 mental healthcare...
Background: Major depressive disorder (MDD) is the leading cause of disability worldwide, affecting roughly 322 million people. Recently, doses of psilocybin have shown promise in treating mood disorders, sparking interest in other dosing practices. According to anecdotal reports and observational studies, microdosing psilocybin yields benefits to mental health; however, rigorously controlled...
Horizonte SanitarioNovember 11, 2025J. Gonzáles, Javier González-Ramírez, Rosario Edith Ortiz-Félix et al.
Objective: To explore the feasibility of the intervention “Mindfulness to Reduce Anxiety in Women with Breast Cancer.” Materials and methods: A pilot study with a quasi-experimental design (pre- and post-test) was conducted. The sample consisted of women aged 30 to 69 years diagnosed with breast cancer who could read and write, had an electronic device with internet access, and had mild or...
Microdosing psychedelics is an increasingly popular phenomenon where small amounts of psychedelic drugs are taken regularly. Qualitative data have been published regarding the experiences of microdosers, but never in the context of a randomised controlled trial. Semi-structured video interviews with 40 healthy males were conducted following a double-blind placebo-controlled trial of 10 µg of...
Major depressive disorder (MDD) affects approximately 5 % of the global population. Classic psychedelics have shown promise in treating various mental health disorders. This study evaluated the feasibility and tolerability of an 8-week regimen of microdosed lysergic acid diethylamide (LSD) as a treatment for major depressive disorder in an open-label phase 2A trial (LSDDEP1). Nineteen...